Fatores relacionados ao risco de feridas em pacientes com Diabetes mellitus Tipo 2

Palavras-chave: Diabetes mellitus, Epidemiologia, Pé diabético, Prevenção secundária, Úlcera do pé

Resumo

Poucos estudos abordam as características sociodemográficas e o risco de feridas no nordeste brasileiro. O objetivo do estudo foi determinar a prevalência de risco de feridas e os fatores relacionados em pessoas com diabetes no município de Parnaíba, estado do Piauí, Brasil. Estudo transversal realizado com 300 pessoas com diabetes. Os voluntários foram avaliados por meio de questionário sociodemográfico, monofilamento de 10 g, diapasão de 128 Hz, martelo de reflexo e escala de classificação de risco de feridas. Sexo masculino (OR 2,33; IC 95% 1,22-4,42), idade (OR 1,03; IC 95% 1,01-1,05), inatividade física (OR 2,35; IC 95% 1,26-4,38) e duração maior de diabetes (OR 3,28; IC 95% 1,56-6,91) foram associados ao risco de feridas. Este estudo demonstrou um alto risco de feridas relacionado a idade, sexo feminino, duração da diabetes e inatividade física e alta prevalência de complicações como a neuropatia periférica diabética e amputações.

Biografia do Autor

Rebeca Barbosa da Rocha, Universidade Federal do Piauí - UFPI
Mestranda no Programa de Pós-Graduação em Ciências Biomédicas. Centro Integrado de Especialidades Médicas, Parnaíba (PI), Brasil
Cristiano Sales da Silva, Universidade Federal do Piauí - UFPI
Professor do Curso de Fisioterapia da Universidade Federal do Piauí. Centro Integrado de Especialidades Médicas, Parnaíba, Piauí, Brasil.
Cristiana Maria dos Santos, Universidade Federal do piauí
Mestranda no Programa de Pós Graduação em Ciências Biomédicas; Centro integrado de especialidades médicas; Parnaíba, Piauí, Brasil
Pedro Renan de Souza Lima da Silveira, Universidade Federal do Piauí - UFPI
Mestrando no Programa de Pós- Graduação em Ciências Biomédicas; Cetro Integrado de Especialidades Médicas; Parnaíba, Piauí, Brasil
Geice Pereira de Sousa, Universidade Federal do Piauí - UFPI
Estudante de Graduação do Curso de Fisioterapia. Centro Integrado de Especialidades Médicas, Parnaíba, Piauí, Brasil
Maria Karliane Arruda Fontenele, Universidade Federal do Piauí - UFPI
Estudante de graduação no Curso de Fisioterapia. Centro Integrado de Especialidades Médicas, Parnaíba, Piauí, Brasil
Vinicius Saura Cardoso, Universidade Federal do Piauí - UFPI
Programa de Pós-Graduação em Ciências Biomédicas. Universidade Federal do Piauí (UFPI). Centro Integrado de Especialidades Médicas. Laboratório Biosignal, Parnaíba (PI), Brasil.

Referências

1. Koc EM, Aksoy H, Ayhan BD, Baydar AA, Kahveci R. Quality assessment of clinical practice guidelines for management of type 2 diabetes mellitus: assessment of type 2 diabetes mellitus guidelines. Diabetes Res Clin Pract. 2019;152:119-24. https://doi.org/10.1016/j.diabres.2019.05.011.

2. Bantie GM, Wondaye AA, Arike EB, Melaku MT, Ejigu ST, Lule A, et al. Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Bahir Dar city, northwest Ethiopia: a community-based cross-sectional study. BMJ Open. 2019;9:e030158. http://dx.doi.org/10.1136/bmjopen-2019-030158.

3. Malta DC, Duncan BB, Schmidt MI, Machado IE, Silva AGD, Bernal RTI, et al. Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, National Health Survey. Rev Bras Epidemiol. 2019;22:e190006. https://doi.org/10.1590/1980-549720190006.supl.2.

4. Stolar M. Glycemic Control and Complications in Type 2 Diabetes Mellitus. Am J Med. 2010;123:S3-S11. https://doi.org/10.1016/j.amjmed.2009.12.004.

5. Porte D Jr. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes Metab Res Rev. 2001;17:181-188. https://doi.org/10.1002/1520-7560(200105/06)17:3<181::AID-DMRR197>3.0.CO;2-1.

6. Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care. 2019;42:416-426. https://doi.org/10.2337/dc17-1144.

7. Misra A, Bloomgarden Z. Metabolic memory: Evolving concepts. J Diabetes. 2018;10:186-187. https://doi.org/10.1111/1753-0407.12622.

8. Bezerra CB, Saintrain MVL, Lima AOP, Nobre MA, Sandrin RLSP, Braga DRA, et al. Clinical and epidemiological differences in diabetes: A cross-sectional study of the Brazilian population compared with the French GERODIAB cohort. Diabetes Res Clin Pract. 2020;159:107945. https://doi.org/10.1016/j.diabres.2019.107945.

9. Cardoso HC, Rosa SSRF, Rocha GA, Rocha JVC, Araújo MCE, Quinzani PF, et al. Risk factors and diagnosis of diabetic foot ulceration in users of the Brazilian public health system. J Diabetes Res. 2019;1-7. https://doi.org/10.1155/2019/5319892.

10. Lucoveis M, Gamba MA, Paula MAB, Morita A. Degree of risk for foot ulcer due to diabetes: nursing assessment. Rev Bras Enferm. 2018;71:3041-7. https://doi.org/10.1590/0034-7167-2017-0189.

11. Tavares TA, Sales MLH, Moraes MM. Fatores de risco para ulceração e amputação de extremidades inferiores em portadores de diabetes mellitus. Rev Bras Promoç Saúde. 2016;29:278-87.

12. Francisco P, Segri NJ, Borim FSA, Malta DC. Prevalence of concomitant hypertension and diabetes in Brazilian older adults: individual and contextual inequalities. Cien Saude Colet. 2018;23:3829-40. https://doi.org/10.1590/1413-812320182311.29662016.

13. Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF). Pak J Med Sci. 2013; 29:730-4. http://dx.doi.org/10.12669/pjms.293.3473.

14. Sample size calculator, 2004, http://www.raosoft.com/samplesize.html.

15. Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K, International Working Group on the Diabetic F. Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Metab Res Rev. 2016;32:7-15. . https://doi.org/10.1002/dmrr.2695.

16. Kishore S, Upadhyay AD, Jyotsna VP. Categories of foot at risk in patients of diabetes at a tertiary care center: Insights into need for foot care. Indian J Endocrinol Metab. 2015;19:405-10. https://doi.org/10.4103/2230-8210.152789.

17. Malgrange D, Richard JL, Leymarie F. Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France. Diabetes Metab. 2003;29:261-8. https://doi.org/10.1016/S1262-3636(07)70035-6.

18. Brinati LM, Diogo NAS, Moreira TR, Mendonça ÉT, Amaro MOF. Prevalence and factors associated with peripheral neuropathy in individuals with diabetes mellitus. Rev Pesqui 2017;9:347-355. http://dx.doi.org/10.9789/2175-5361.rpcfo.v9.4476.

19. Darivemula S, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and its associated determinants of diabetic peripheral neuropathy (DPN) in individuals having type-2 diabetes mellitus in rural South India. Indian J Community Med. 2019;44:88-91. https://doi.org/10.4103/ijcm.IJCM_207_18.

20. Tomasi E, Cesar MA, Neves RG, Schmidt PR, Thumé E, da Silveira DS, et al. Diabetes Care in Brazil: Program to Improve Primary Care Access and Quality-PMAQ. J Ambul Care Manage. 2017;40:S12-S23.

21. Hasan MM, Tasnim F, Tariqujjaman M, Ahmed S. Socioeconomic Inequalities of Undiagnosed Diabetes in a Resource-Poor Setting: Insights from the Cross-Sectional Bangladesh Demographic and Health Survey 2011. Int J Environ Res Public Health. 2019;16:115. https://doi.org/10.3390/ijerph16010115.

22. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81. https://doi.org/10.1016/j.diabres.2018.02.023.

23. Brito KM, Bruzo RAC, Salado GA. Estilo de vida e hábitos alimentares de pacientes diabéticos. Revista Saúde e Pesqui. 2009;2(3):357-362.

24. Viana LV, Leitão CB, Kramer CK, Zucatti ATN, Jezini DL, Felício J, et al. Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open. 2013;3:e003336. http://dx.doi.org/10.1136/bmjopen-2013-003336.

25. Doucet JA, Bauduceau B, Le Floch JP, Verny C, Intergroup SS. Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort. Fundam Clin Pharmacol. 2016;30:76-81. https://doi.org/10.1111/fcp.12160.

26. Salci MA, Meirelles BH, Silva DM. Primary care for diabetes mellitus patients from the perspective of the care model for chronic conditions. Rev Lat Am Enfermagem. 2017;25:e2882. https://doi.org/10.1590/1518-8345.1474.2882.

27. Costa JSD, Olinto MTA, Gigante DP, Menezes AMB, Macedo S, Daltoé T, et al. Use of outpatient services in Pelotas, Rio Grande do Sul State, Brazil: factors related to above average number of physician visits. Cad Saúde Pública. 2008;24:353-363. http://dx.doi.org/10.1590/S0102-311X2008000200014.

28. Costa JSD, Teixeira AMFB, Moraes M, Strauch ES, Silveira DS, Carret MLV, Fantinel E. Hospitalizations for primary care-sensitive conditions in Pelotas, Brazil: 1998 to 2012. Rev bras epidemiol. 2017;20:345-354. http://dx.doi.org/10.1590/1980-5497201700020014.

29. Cortez DN, Reis IA, Souza DAS, Macedo MML, Torres HDC. Complicações e o tempo de diagnóstico do diabetes mellitus na atenção primária. Acta Paul Enferm. 2015;28:250-5. https://doi.org/10.1590/1982-0194201500042.

30. Sayah FA, Soprovich A, Qiu W, Edwards AL, Johnson JA. Diabetic Foot Disease, Self-Care and Clinical Monitoring in Adults with Type 2 Diabetes: The Alberta’s Caring for Diabetes (ABCD) Cohort Study. Can J Diabetes. 2015;39:S120-S126. https://doi.org/10.1016/j.jcjd.2015.05.006.

Publicado
2022-08-29
Seção
Artigos Originais